Upadacitinib Shows Efficacy in Psoriasis Coexisting With Lichen Planus
A Frontiers case report documents effective treatment of concurrent psoriasis and lichen planus with the JAK1 inhibitor upadacitinib, adding precedent for single-agent overlap therapy.